The Senate Committee on Health, Education, Labor and Pensions (HELP) voted 12-11 on Wednesday to advance Nicole Saphier, MD — a radiologist and director of breast imaging at Memorial Sloan Kettering — as President Trump's nominee for U.S. Surgeon General. She is Trump's third pick for the role, following the withdrawn nominations of Casey Means and Janette Nesheiwat.

Saphier faced pointed questioning at her confirmation hearing earlier this month, particularly around childhood vaccines. She stated clearly that she does not believe vaccines cause autism and called the MMR vaccine "our greatest tool for combating measles" — a notable stance given the Trump administration's history of revisiting vaccine-autism claims. Sen. Bernie Sanders voted against her, citing concerns that she had previously questioned the universal hepatitis B birth dose.

The Surgeon General role carries limited direct policymaking power but holds significant influence as the nation's chief public health communicator.

Key Takeaways:

• Saphier was advanced on a narrow 12-11 vote; a full Senate confirmation vote is expected but not yet scheduled
• Timothy Westlake, MD, nominated as assistant secretary for mental health and substance use at HHS, was advanced in the same vote
• The Surgeon General is described by HHS as the "Nation's Doctor," responsible for communicating the best available health science to the public

Why it matters: The Surgeon General serves as America's top public health voice — and who fills that role has real consequences for how the nation communicates on vaccines, disease prevention, and health guidance. Saphier's confirmation would put a physician with mainstream vaccine views in a high-profile position at a time of significant public health debate.